- Home
- MOB vs PMVP Comparison
MOB vs PMVP Comparison
Compare MOB & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOB
- PMVP
- Stock Information
- Founded
- MOB 2008
- PMVP 2013
- Country
- MOB Israel
- PMVP United States
- Employees
- MOB N/A
- PMVP N/A
- Industry
- MOB Real Estate Investment Trusts
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- MOB Real Estate
- PMVP Health Care
- Exchange
- MOB Nasdaq
- PMVP Nasdaq
- Market Cap
- MOB 83.2M
- PMVP 76.8M
- IPO Year
- MOB 2022
- PMVP 2020
- Fundamental
- Price
- MOB $7.45
- PMVP $1.55
- Analyst Decision
- MOB Strong Buy
- PMVP Strong Buy
- Analyst Count
- MOB 1
- PMVP 1
- Target Price
- MOB $10.00
- PMVP $5.00
- AVG Volume (30 Days)
- MOB 672.6K
- PMVP 562.4K
- Earning Date
- MOB 08-12-2025
- PMVP 11-06-2025
- Dividend Yield
- MOB N/A
- PMVP N/A
- EPS Growth
- MOB N/A
- PMVP N/A
- EPS
- MOB N/A
- PMVP N/A
- Revenue
- MOB $2,826,361.00
- PMVP N/A
- Revenue This Year
- MOB $142.38
- PMVP N/A
- Revenue Next Year
- MOB $99.99
- PMVP N/A
- P/E Ratio
- MOB N/A
- PMVP N/A
- Revenue Growth
- MOB N/A
- PMVP N/A
- 52 Week Low
- MOB $1.28
- PMVP $0.81
- 52 Week High
- MOB $11.02
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- MOB 44.73
- PMVP 60.15
- Support Level
- MOB $7.10
- PMVP $1.38
- Resistance Level
- MOB $8.75
- PMVP $1.50
- Average True Range (ATR)
- MOB 1.18
- PMVP 0.10
- MACD
- MOB -0.35
- PMVP 0.01
- Stochastic Oscillator
- MOB 8.95
- PMVP 98.00
About MOB Mobilicom Limited
Mobilicom Ltd is a provider of cybersecurity and smart solutions for drones, robotics & autonomous platforms. As a high-tech company, it designs, develops, and delivers smart solutions targeting global drone, robotics, and autonomous system manufacturers. Its products include OS3 Platform Software, ICE Cybersecurity Software, MCU Mesh Networking, SkyHopper Datalinks, Mobile Ground Control Stations and System Engineering Services.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.